SANOFINSESanofi India Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 2 Apr · 19:03 IST

Sanofi India Limited has informed the Exchange regarding Business Responsibility and Sustainability Report for the financial year ended 31st December 2025

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.2%1-day move
₹3262.00
prior close
₹3290.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.6+0.5-0.3-0.1+4.2+4.9+5.8+6.8+6.7+9.0+6.1+4.2-2.0+6.1
Up moveDown movePending
AI summary

Sanofi India Limited filed its BRSR for the financial year ended 31st December 2025, as required under SEBI Listing Regulations. The company reported standalone turnover of ₹18,374 million with 1,104 total employees (871 permanent employees and 226 permanent workers). Women represent 16% of the workforce and 11% of the Board. The company achieved a 70% reduction in Scope 1 and 2 GHG emissions versus 2019 baseline and 74% renewable electricity usage. Key ESG targets include Net Zero by 2045, 55% Scope 1&2 reduction by 2030, and 100% renewable electricity by 2030. Customer complaints numbered 1,254 with nil pending resolution, while employee grievances stood at 29 with 7 pending. No regulatory fines or penalties were recorded during the year.

Likely market impact

The filing demonstrates Sanofi India's commitment to ESG principles with measurable progress on climate targets. The strong governance structure, no penalties, and high employee welfare coverage (100% health, accident insurance, PF, ESI) are positive indicators for investors. The high volume of customer complaints (1,254) warrants monitoring but shows effective resolution mechanisms.